1-156623506-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_021817.3(HAPLN2):c.16A>G(p.Thr6Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_021817.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HAPLN2 | NM_021817.3 | c.16A>G | p.Thr6Ala | missense_variant | Exon 3 of 7 | ENST00000255039.6 | NP_068589.1 | |
HAPLN2 | XM_011509853.3 | c.16A>G | p.Thr6Ala | missense_variant | Exon 3 of 7 | XP_011508155.1 | ||
HAPLN2 | XM_017002020.2 | c.16A>G | p.Thr6Ala | missense_variant | Exon 4 of 8 | XP_016857509.1 | ||
HAPLN2 | XM_047427123.1 | c.258A>G | p.Ser86Ser | synonymous_variant | Exon 4 of 5 | XP_047283079.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HAPLN2 | ENST00000255039.6 | c.16A>G | p.Thr6Ala | missense_variant | Exon 3 of 7 | 1 | NM_021817.3 | ENSP00000255039.1 | ||
HAPLN2 | ENST00000456112.1 | c.16A>G | p.Thr6Ala | missense_variant | Exon 3 of 5 | 5 | ENSP00000388835.1 | |||
HAPLN2 | ENST00000482204.1 | n.271A>G | non_coding_transcript_exon_variant | Exon 3 of 3 | 2 | |||||
HAPLN2 | ENST00000487988.5 | n.435A>G | non_coding_transcript_exon_variant | Exon 3 of 3 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.16A>G (p.T6A) alteration is located in exon 3 (coding exon 1) of the HAPLN2 gene. This alteration results from a A to G substitution at nucleotide position 16, causing the threonine (T) at amino acid position 6 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at